July 20, 2016 7:44 AM | 1 min read |
27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.
St. Jude Medical, Inc. (NYSE: STJ) announced 18 percent drop in net income for the second quarter despite sales witnessing 10.64 growth. However, its adjusted earnings, which increased three percent, came in line with the expectations.St. Jude Medical reported net income of $238 million, down 18 percent from $290 million while earnings fell 18.6 percent to $0.83 a share from $1.02 a share in the year-ago quarter. On an adjusted basis, it would have earned $1.06 compared to $1.03, matching the Street analysts' estimations.Net sales grew 10.6 percent to $1.56 billion from $1.41 billion in the previous year quarter. This was also in line with the analysts' expectations. On a comparable constant currency basis, the growth would have been two percent.Its President and CEO, Michael Rousseau, commented, "One of the major highlights of our quarter was the announcement of our pending merger with Abbott. We continue to be confident and excited about the potential of our combined organization and the powerful impact we can have on delivering industry leading innovation to physicians and patients around the world."In the pre-market trading on Wednesday, the stock traded 0.20 percent higher.
27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.